227 related articles for article (PubMed ID: 15102675)
1. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer.
Pandya AY; Talley LI; Frost AR; Fitzgerald TJ; Trivedi V; Chakravarthy M; Chhieng DC; Grizzle WE; Engler JA; Krontiras H; Bland KI; LoBuglio AF; Lobo-Ruppert SM; Ruppert JM
Clin Cancer Res; 2004 Apr; 10(8):2709-19. PubMed ID: 15102675
[TBL] [Abstract][Full Text] [Related]
2. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
[TBL] [Abstract][Full Text] [Related]
3. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
4. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
[TBL] [Abstract][Full Text] [Related]
5. Association of expression of kruppel-like factor 4 and kruppel-like factor 5 with the clinical manifestations of breast cancer.
Chen CJ; Lin SE; Lin YM; Lin SH; Chen DR; Chen CL
Pathol Oncol Res; 2012 Apr; 18(2):161-8. PubMed ID: 21674249
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
7. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
8. Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.
Gehrau RC; D'Astolfo DS; Dumur CI; Bocco JL; Koritschoner NP
PLoS One; 2010 Jan; 5(1):e8929. PubMed ID: 20126619
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
[TBL] [Abstract][Full Text] [Related]
11. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL
Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423
[TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptor-alpha and Ki67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma.
Ding SL; Sheu LF; Yu JC; Yang TL; Chen B; Leu FJ; Shen CY
J Biomed Sci; 2004; 11(6):911-9. PubMed ID: 15591788
[TBL] [Abstract][Full Text] [Related]
13. Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers.
Rehman S; Crow J; Revell PA
Pathol Oncol Res; 2000; 6(4):256-63. PubMed ID: 11173657
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer.
Zahnow CA; Younes P; Laucirica R; Rosen JM
J Natl Cancer Inst; 1997 Dec; 89(24):1887-91. PubMed ID: 9414177
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas.
Jones J; Wang H; Karanam B; Theodore S; Dean-Colomb W; Welch DR; Grizzle W; Yates C
Clin Exp Metastasis; 2014 Jun; 31(5):497-510. PubMed ID: 24570268
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.
Heinonen M; Bono P; Narko K; Chang SH; Lundin J; Joensuu H; Furneaux H; Hla T; Haglund C; Ristimäki A
Cancer Res; 2005 Mar; 65(6):2157-61. PubMed ID: 15781626
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma.
Li X; Zhao Z; Yi S; Ma L; Li M; Liu M; Zhang Y; Liu G
J Transl Med; 2018 Jul; 16(1):183. PubMed ID: 29973197
[TBL] [Abstract][Full Text] [Related]
18. Expression of alpha B crystallin and BCL2 in patients with infiltrating ductal carcinoma.
Kim MS; Lee HW; Jun SY; Lee EH
Int J Clin Exp Pathol; 2015; 8(8):8842-56. PubMed ID: 26464626
[TBL] [Abstract][Full Text] [Related]
19. COX2 overexpression is a prognostic marker for Stage III breast cancer.
Kim HS; Moon HG; Han W; Yom CK; Kim WH; Kim JH; Noh DY
Breast Cancer Res Treat; 2012 Feb; 132(1):51-9. PubMed ID: 21533532
[TBL] [Abstract][Full Text] [Related]
20. Kruppel-like factor 4 regulates laminin alpha 3A expression in mammary epithelial cells.
Miller KA; Eklund EA; Peddinghaus ML; Cao Z; Fernandes N; Turk PW; Thimmapaya B; Weitzman SA
J Biol Chem; 2001 Nov; 276(46):42863-8. PubMed ID: 11551969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]